In 100 infants born before 30 weeks with prethreshold ROP, dexamethasone eye drops vs placebo did not significantly reduce progression to type 1 ROP needing treatment (20.0% vs 38.0%; adjusted OR 0.44, 95% CI 0.17-1.12). No clear adverse event differences.
RCTn = 100
Hellström et al. Dexamethasone Eye Drops to Prevent Treatment-Requiring Retinopathy of Prematurity: The DROPROP Randomized Clinical Trial